Skip to main content

and
  1. No Access

    Article

    Five Dimensions of Needs for Help: The Efficacy of a Technology-Based Intervention Among Asian American Breast Cancer Survivors

    Cancer survivors including Asian American breast cancer survivors have reported their high needs for help during their survivorship process. With the COVID-19 pandemic, the necessity of technology-based progra...

    Eun-Ok Im, Wonshik Chee, Sudeshna Paul, Mi-Young Choi in Journal of Cancer Education (2024)

  2. No Access

    Article

    Anti-tumor effect of CDK inhibitors on CDKN2A-defective squamous cell lung cancer cells

    Squamous cell lung cancer (SqCLC) is a distinct histologic subtype of non-small cell lung cancer (NSCLC). Although the discovery of driver mutations and their targeted drugs has remarkably improved the treatme...

    Eun-Hui Jeong, Tae-Gul Lee, Yun Jung Ko, Seo Yun Kim, Hye-Ryoun Kim in Cellular Oncology (2018)

  3. No Access

    Article

    Sex-specific incidence of EGFR mutation and its association with age and obesity in lung adenocarcinomas: a retrospective analysis

    Age and obesity are well-known risk factors for various cancers, but the potential roles of age and obesity in lung cancer, especially in those with activating EGFR mutations, have not been thoroughly evaluated. ...

    Hye-Ryoun Kim, Seo Yun Kim, Cheol Hyeon Kim in Journal of Cancer Research and Clinical On… (2017)

  4. No Access

    Article

    Gefitinib induces cytoplasmic translocation of the CDK inhibitor p27 and its binding to a cleaved intermediate of caspase 8 in non-small cell lung cancer cells

    The epidermal growth factor receptor (EGFR) represents one of the first rationally selected molecules for targeted therapy in non-small cell lung cancer (NSCLC). Gefitinib is a reversible and highly selective ...

    Sun Hee Ahn, Eun-Hui Jeong, Tae-Gul Lee, Seo Yun Kim, Hye-Ryoun Kim in Cellular Oncology (2014)